Publication & Citation Trends
Publications
10 total
AZD5438, a potent oral inhibitor of cyclin-dependent kinases 1, 2, and 9, leads to pharmacodynamic changes and potent antitumor effects in human tumor xenografts
Cited by 122
OpenAlex
Discovery of imidazole vinyl pyrimidines as a novel class of kinase inhibitors which inhibit Tie-2 and are orally bioavailable PDF
Cited by 9
OpenAlex
The cellular phenotype of AZ703, a novel selective imidazo[1,2-<i>a</i>]pyridine cyclin-dependent kinase inhibitor PDF
Cited by 48
OpenAlex
Research Topics
Cancer-related Molecular Pathways
(5)
Advanced Breast Cancer Therapies
(5)
Microtubule and mitosis dynamics
(3)
Synthesis and biological activity
(2)
Angiogenesis and VEGF in Cancer
(2)
Affiliations
AstraZeneca (United Kingdom)
University of Leicester